Cargando…

Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-κB/LCN-2 signaling pathway in inflammatory microenvironment

This study explored the possible connection between the insulin resistance-targeting protein adipokine lipocalin-2 (LCN-2) and NF-κB signaling pathway in the inflammatory microenvironment in PCOS-IR model rats to determine the pharmacological mechanism of modified Cangfu Daotan decoction (MCDD) inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shuowen, Zhang, Yao, Yang, Fang, Gu, Jingna, Zhang, Ruyue, Kuang, Yingying, Mai, Wantong, Zheng, Chengbo, Yu, Yang, Lu, Ruling, Zeng, Lei, Cao, Hongying, Long, Yongling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686851/ https://www.ncbi.nlm.nih.gov/pubmed/36440213 http://dx.doi.org/10.3389/fendo.2022.975724

Ejemplares similares

Cangfu daotan decoction for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Park, Hye-Rin, et al.
Publicado: (2019)

Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Linling, et al.
Publicado: (2022)

Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology
por: Xu, Wenting, et al.
Publicado: (2020)

Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis
por: Li, Yuan, et al.
Publicado: (2023)

Effects of Changyu Daotan Decoction on Depression via Restoration of Mice Hippocampus and Alteration of Expression of Relevant Neurotrophic Factors
por: Zhang, Suifeng, et al.
Publicado: (2022)

Mechanism of Xiaoying Daotan decoction in treating Hashimoto’s thyroiditis based on the Notch/Treg/Th17 pathway
por: Zhou, Yingjia, et al.
Publicado: (2021)

Retracted: Effects of Changyu Daotan Decoction on Depression via Restoration of Mice Hippocampus and Alteration of Expression of Relevant Neurotrophic Factors
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Molecular mechanism of modified Huanglian Wendan decoction in the treatment of polycystic ovary syndrome
por: Wu, Zhaojing, et al.
Publicado: (2023)

A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome
por: Liu, Lihong, et al.
Publicado: (2018)

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
por: Shan, Hongying, et al.
Publicado: (2022)

Effect of Wenshentiaojing Decoction on Hormone Level and Follicular Number in Patients with Menstrual Disorder of Polycystic Ovary Syndrome
por: Li, Lanzhi, et al.
Publicado: (2021)

Integrated Network Pharmacology and Clinical Study to Reveal the Effects and Mechanisms of Bushen Huoxue Huatan Decoction on Polycystic Ovary Syndrome
por: Ding, Jie, et al.
Publicado: (2022)

The role of LCN2 and LCN2-MMP9 in spondylitis radiographic development: gender and HLA-B27 status differences
por: Tsui, Florence W. L., et al.
Publicado: (2022)

Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome
por: Li, Wenqian, et al.
Publicado: (2022)

Identification, characterization and expression analysis of rLcn13, an epididymal lipocalin in rats : Characterization of epididymal-specific lipicalin rLcn13
por: Yao, Guangxin, et al.
Publicado: (2023)

Nourishing Kidney Promoting Ovulation Decoction (NKPOD) Attenuates Polycystic Ovary Syndrome by Downregulating miRNA-224
por: Guo, Yinhua, et al.
Publicado: (2023)

The effect of lipocalin-2 (LCN2) on apoptosis: a proteomics analysis study in an LCN2 deficient mouse model
por: Wu, Dongming, et al.
Publicado: (2021)

Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial
por: Li, Yan, et al.
Publicado: (2013)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

LCN6, a novel human epididymal lipocalin
por: Hamil, Katherine G, et al.
Publicado: (2003)

A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance
por: Shi, Na, et al.
Publicado: (2022)

Efficacy of clomifene citrate combined Bushen Culuan Decoction for the treatment of infertility caused by polycystic ovary syndrome: A protocol of systematic review
por: Feng, Jing, et al.
Publicado: (2020)

Acupuncture and Clomiphene Citrate for Live Birth in Polycystic Ovary Syndrome: Study Design of a Randomized Controlled Trial
por: Kuang, Hongying, et al.
Publicado: (2013)

Polycystic ovary syndrome and mitochondrial dysfunction
por: Zhang, Jingshun, et al.
Publicado: (2019)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome
por: Kuang, Hongying, et al.
Publicado: (2020)

Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled trial
por: Li, Yan, et al.
Publicado: (2013)

Resistance to the Bacteriocin Lcn972 Deciphered by Genome Sequencing
por: Escobedo, Susana, et al.
Publicado: (2023)

Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome
por: Du, Tao, et al.
Publicado: (2015)

Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Is interleukin-18 associated with polycystic ovary syndrome?
por: Yang, Yan, et al.
Publicado: (2011)

Shaoyao-Gancao Decoction alleviated hyperandrogenism in a letrozole-induced rat model of polycystic ovary syndrome by inhibition of NF-κB activation
por: Shao, Yun-yun, et al.
Publicado: (2019)

LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qu85rk1au9cpi92oolcm28h9t6